Skip to content
Clinical Trials – home
Merck Healthcare KGaA
Sponsor

Merck Healthcare KGaA

Germany Frankfurter Strasse 250, 64293 Darmstadt, Germany

About the sponsor

Clinical activity spans advanced solid tumors, non-small cell lung cancer, lung cancer, gastric cancer, pancreatic ductal adenocarcinoma, epithelial ovarian cancer, and colorectal cancer, with additional interest in metastatic and locally advanced unresectable tumors.

  • METex14 skipping alterations and MET amplification
  • EGFR-mutated lung cancer
  • CEACAM5-targeted solid tumor programs
  • DNA damage response and topoisomerase 1-based combinations

Research also includes head and neck squamous cell carcinoma, reflecting a broad oncology portfolio across thoracic, gastrointestinal, and upper aerodigestive malignancies.

About Specializations

Merck Healthcare KGaA runs clinical trials in conditions such as Cutaneous lupus erythematosus, Systemic lupus erythematosus, Chronic cutaneous lupus erythematosus, Subacute cutaneous lupus erythematosus, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

17 clinical trials

Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Merck Healthcare KGaA
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Sponsor:Merck Healthcare KGaA
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Sponsor:Merck Healthcare KGaA
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cladribine
  • Sponsor:Merck Healthcare KGaA
Countries:GermanyGermany
  • Participants:0–17 years
  • Sponsor:Merck Healthcare KGaA
InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Sponsor:Merck Healthcare KGaA
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Enpatoran
  • Sponsor:Merck Healthcare KGaA
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Tuvusertib
  • Sponsor:Merck Healthcare KGaA
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Sponsor:Merck Healthcare KGaA
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Sponsor:Merck Healthcare KGaA
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Xevinapant
  • Sponsor:Merck Healthcare KGaA
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Enpatoran
  • Sponsor:Merck Healthcare KGaA

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.